Laurie Kevorkian
About Laurie Kevorkian
Laurie Kevorkian serves as the Responsable Développement Vétérinaire at Dechra Pharmaceuticals PLC, a position she has held since 2020. She has a background in veterinary studies and marketing, with previous roles at Vetoquinol Global and a strong educational foundation from prestigious institutions.
Work at Dechra Pharmaceuticals
Laurie Kevorkian currently holds the position of Responsable Développement Vétérinaire at Dechra Pharmaceuticals PLC, a role she has occupied since 2020. In this capacity, she is responsible for veterinary development initiatives within the company. Prior to this, she worked as Responsable Marketing et Technique Grands Animaux at Dechra Pharmaceuticals from 2018 to 2020, where she focused on marketing and technical aspects related to large animals.
Previous Experience at Vetoquinol Global
Laurie Kevorkian has previous experience with Vetoquinol Global, where she served as Responsable technique et marketing - Produits vétérinaires for a period of seven months in 2018. Additionally, she worked as Chef de produit et responsable technique - Animaux de rente et équidés from 2017 to 2018, focusing on product management and technical responsibilities for livestock and equine products.
Education and Expertise
Laurie Kevorkian studied at Ecole nationale vétérinaire de Toulouse from 2006 to 2010, where she completed her veterinary education. She further specialized in equine studies at Ecole nationale vétérinaire de Nantes from 2010 to 2011. Additionally, she holds a Master of Science in Marketing from HEC Paris, which she completed from 2015 to 2016. This educational background provides her with a strong foundation in veterinary science and marketing.
Professional Development Timeline
Laurie Kevorkian's professional journey includes significant roles in veterinary development and marketing. After completing her studies, she began her career in product management in 2017. She transitioned to Vetoquinol Global in 2018 and then joined Dechra Pharmaceuticals, where she has continued to advance her career in veterinary development since 2020.